Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-030603
Filing Date
2024-08-07
Accepted
2024-08-07 17:21:17
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1205510
2 ex10-1.htm EX-10.1 56457
3 ex10-2.htm EX-10.2 34556
4 ex31-1.htm EX-31.1 17982
5 ex31-2.htm EX-31.2 17834
6 ex32-1.htm EX-32.1 7645
  Complete submission text file 0001493152-24-030603.txt   5529758

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE fblg-20240630.xsd EX-101.SCH 37072
8 XBRL CALCULATION FILE fblg-20240630_cal.xml EX-101.CAL 52847
9 XBRL DEFINITION FILE fblg-20240630_def.xml EX-101.DEF 199865
10 XBRL LABEL FILE fblg-20240630_lab.xml EX-101.LAB 324599
11 XBRL PRESENTATION FILE fblg-20240630_pre.xml EX-101.PRE 281651
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 730731
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41934 | Film No.: 241185085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)